Todos is a victim being a small company on OTC. Th
Post# of 30027
(Total Views: 377)
Posted On: 01/28/2022 3:25:10 PM
Todos is a victim being a small company on OTC. The same news by any of the big pharmas would have generated $bil in stock appreciation. GC has to find a way to get on the big business networks to get the story out. I’m sure the company is working on it but I can also imagine interested parties who might be trying to stop it.
The next big PR opportunity is the admission of EUA application in the near future.
The next big PR opportunity is the admission of EUA application in the near future.
(2)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼